384 filings
Page 3 of 20
8-K
zpdr984ud2
3 Dec 19
Departure of Directors or Certain Officers
4:16pm
8-K
e23cwac9pue4
15 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
6zp9ueno2d 5gyqdeq
7 Nov 19
Savara Reports Third Quarter 2019 Financial Results
4:06pm
8-K
j36tf1pere3bgr7xf5b3
2 Oct 19
Regulation FD Disclosure
8:11am
8-K
oro5apo k1rqx
8 Aug 19
Savara Reports Second Quarter 2019 Financial Results
4:21pm
8-K
ddkpkz
27 Jun 19
Entry into a Material Definitive Agreement
4:06pm
8-K
yctkx l9t0
12 Jun 19
Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment
4:13pm
8-K
asqw9nv9g
31 May 19
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
rlztd7cafnsonj7fd
28 May 19
Entry into a Material Definitive Agreement
4:25pm
8-K
vc10d7
9 May 19
Savara Reports First Quarter 2019 Financial Results
4:10pm
8-K
87smf7 5yrl5bukc08t
30 Apr 19
Entry into a Material Definitive Agreement
4:10pm
8-K
x0vlbmz8wuesf4dapf
15 Apr 19
Changes in Registrant's Certifying Accountant
4:40pm
8-K
mfcewkqck38vrn7num
3 Apr 19
Changes in Registrant's Certifying Accountant
4:10pm
8-K
lao4gddr7w lpioqsl
13 Mar 19
Savara Reports Fourth Quarter and Full Year 2018 Financial Results
4:14pm
8-K
bnqyx2mf6 i1rgaok0
19 Dec 18
Savara Announces Interim Results for Optima Clinical Study
8:26am
8-K
qvsb6iob
14 Dec 18
Departure of Directors or Certain Officers
4:05pm
8-K
haljzeu
7 Dec 18
Entry into a Material Definitive Agreement
4:06pm
8-K
p1xjl7kocc6732zwd0
7 Nov 18
Savara Reports Third Quarter 2018 Financial Results
4:12pm
8-K
cfz67
9 Aug 18
Savara Reports Second Quarter 2018 Financial Results
4:08pm
8-K
u4sfaq jf
6 Aug 18
Departure of Directors or Certain Officers
12:00am